Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.

Journal of Cancer Epidemiology
Mark D DaneseRobert I Griffiths

Abstract

Background. Trastuzumab improves survival in HER2-positive women with metastatic breast cancer (MBC). The consequences of longer survival include a higher likelihood of additional metastases, including those in the central nervous system (CNS). The effect of CNS metastases on both trastuzumab discontinuation and survival in older patients has not been described. Patients and Methods. We used the Surveillance Epidemiology and End Results (SEER) Medicare data to identify a cohort of 562 women age 66 or older with MBC who were diagnosed between January 1, 2000 and December 31, 2005, free of CNS metastases, and initiated trastuzumab after MBC diagnosis. Time to discontinuation and time to death were analyzed using proportional hazards models. Results. Newly diagnosed CNS metastases were associated with both higher risk of trastuzumab discontinuation (relative hazard [RH] = 1.78, 95% CI 1.11-2.87) and higher risk of death (RH = 2.49, 95% CI 1.84-3.37). The incidence rate of new CNS metastases was comparable among various sites of metastasis (10.7 to 14.7 per 1,000 patient-months), except for bone which was higher (24.1 per 1,000). Conclusion. The diagnosis of CNS metastases was associated with an increase in both the likelihood of d...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Jan 9, 2001·Journal of Clinical Epidemiology·C N KlabundeJ L Warren
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K D MillerG W Sledge
Sep 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Leyland-JonesParviz Ghahramani
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jill S Barnholtz-SloanRaymond E Sawaya
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaParviz Ghahramani
Jul 20, 2005·The Breast : Official Journal of the European Society of Mastology·H J StemmlerV Heinemann
Apr 11, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B C PestalozziUNKNOWN International Breast Cancer Study Group (IBCSG)
Sep 21, 2006·Journal of the National Cancer Institute·Elizabeth B LamontUNKNOWN Cancer and Leukemia Group B
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nancy U Lin, Eric P Winer
Jun 9, 2007·Journal of Neuro-oncology·Rupert BartschGuenther G Steger
Jul 6, 2007·The New England Journal of Medicine·Clifford A Hudis
Dec 7, 2007·American Journal of Epidemiology·Samy Suissa
Mar 13, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodA M Gonzalez-Angulo
Apr 3, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael E StokesCraig C Earle
Jun 30, 2009·Journal of Neuro-oncology·April F Eichler, Elizabeth B Lamont
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Leyland-Jones
Jul 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam M BrufskyDenise A Yardley

❮ Previous
Next ❯

Software Mentioned

SEER

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.